Literature DB >> 1728449

Valvular heart disease in four patients with Maroteaux-Lamy syndrome.

C T Tan1, H V Schaff, F A Miller, W D Edwards, P S Karnes.   

Abstract

BACKGROUND: Maroteaux-Lamy syndrome is a lysosomal storage disease of mucopolysaccharide metabolism (MPS type VI) that may involve the mitral and aortic valves. Affected patients have other skeletal and oropharyngeal malformations that complicate anesthetic and surgical management. METHODS AND
RESULTS: The present report describes the clinical, echocardiographic, and pathological findings in four patients with Maroteaux-Lamy syndrome. Two of three siblings underwent successful double-valve replacement for aortic and mitral valve stenoses. The third sibling, whose aortic and mitral valves were thick and fibrotic, died from septicemia after hip surgery. A fourth, unrelated patient also had successful double-valve replacement.
CONCLUSIONS: Our experience emphasizes the potential difficulties in preoperative assessment and surgical treatment as well as the unique problems related to airway management in patients with this syndrome.

Entities:  

Mesh:

Year:  1992        PMID: 1728449     DOI: 10.1161/01.cir.85.1.188

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy.

Authors:  Fabiano de Oliveira Poswar; Carolina Fischinger Moura de Souza; Roberto Giugliani; Guilherme Baldo
Journal:  Heart Vessels       Date:  2018-08-22       Impact factor: 2.037

2.  Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI cats.

Authors:  Katherine P Ponder; Thomas M O'Malley; Ping Wang; Patricia A O'Donnell; Anne M Traas; Van W Knox; Gustavo A Aguirre; N Matthew Ellinwood; Jason A Metcalf; Bin Wang; Emma J Parkinson-Lawrence; Meg M Sleeper; Doug A Brooks; John J Hopwood; Mark E Haskins
Journal:  Mol Ther       Date:  2012-03-06       Impact factor: 11.454

Review 3.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

4.  Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up.

Authors:  E Herskhovitz; E Young; J Rainer; C M Hall; V Lidchi; K Chong; A Vellodi
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

5.  Combined aortic and mitral valve replacement in an adult with mucopolysaccharidosis (Maroteaux-Lamy syndrome).

Authors:  M Hachida; M Nonoyama; Y Bonkohara; N Hanayama; H Koyanagi
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

Review 6.  Mucopolysaccharidosis VI.

Authors:  Vassili Valayannopoulos; Helen Nicely; Paul Harmatz; Sean Turbeville
Journal:  Orphanet J Rare Dis       Date:  2010-04-12       Impact factor: 4.123

7.  Early diagnosis of Maroteaux-Lamy syndrome in two patients with accelerated growth and advanced bone maturation.

Authors:  Delphine Heron; Clarisse Baumann; Jean Jacques Benichou; Jean Paul Harpey; Martine Le Merrer
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

8.  Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses.

Authors:  C F Wippermann; M Beck; D Schranz; R Huth; I Michel-Behnke; B K Jüngst
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

9.  Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy.

Authors:  Christoph Kampmann; Christina Lampe; Catharina Whybra-Trümpler; Christiane M Wiethoff; Eugen Mengel; Laila Arash; Michael Beck; Elke Miebach
Journal:  J Inherit Metab Dis       Date:  2013-09-24       Impact factor: 4.982

10.  Electrocardiographic and other cardiac anomalies in beta-glucuronidase-null mice corrected by nonablative neonatal marrow transplantation.

Authors:  A J T Schuldt; T J Hampton; V Chu; C A Vogler; N Galvin; M D Lessard; J E Barker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.